NTLA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Intellia Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Portfolio Pulse from
A class action lawsuit has been filed against Intellia Therapeutics, Inc. (NASDAQ:NTLA) by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges violations of federal securities laws for investors who acquired Intellia securities between July 30, 2024, and January 8, 2025.
February 21, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Intellia Therapeutics is facing a class action lawsuit for alleged securities law violations, potentially impacting its stock price negatively in the short term.
The announcement of a class action lawsuit against Intellia Therapeutics for alleged securities law violations is likely to create negative sentiment among investors, potentially leading to a short-term decline in the stock price. Legal issues can cause uncertainty and affect investor confidence.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100